The Impact of Surgical Treatment of Endometriomas on Ovarian Reserve
1 other identifier
interventional
20
1 country
1
Brief Summary
The aim of this study is to assess which of two commonly used surgical procedures in the treatment of ovarian cysts called endometriomas (cutting out of the cyst - "cystectomy", or draining it and cauterising it's inner lining - "ablation") causes the least damage to the ovary and is therefore best at maintaining the future fertility potential of a patient.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2011
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2011
CompletedFirst Submitted
Initial submission to the registry
August 25, 2011
CompletedFirst Posted
Study publicly available on registry
August 30, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2013
CompletedAugust 30, 2011
August 1, 2011
1.3 years
August 25, 2011
August 26, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Anti-Mullerian Hormone (AMH)
Change in anti-mullerian hormone level after surgery (at one week, three months and six months)
6 months post-operatively
Secondary Outcomes (2)
Follicle Stimulating Hormone (FSH)
6 months
Antral Follicle Count (AFC)
3 months
Study Arms (2)
Cystectomy
ACTIVE COMPARATORPatients undergoing cystectomy for ovarian endometrioma
Ablation
ACTIVE COMPARATORPatients undergoing ablation for ovarian endometrioma
Interventions
Patients undergoing surgery for ovarian endometrioma
Eligibility Criteria
You may qualify if:
- Women undergoing laparoscopic surgery for treatment of unilateral endometriomas measuring ≥ 3cm and ≤ 8cm in diameter
You may not qualify if:
- Patients who have received oestrogen suppressing drugs (e.g. oral contraceptive pills, GnRHa) during the previous six months
- Patients who have previously undergone surgical treatment of endometriomas
- Patients with bilateral endometriomas
- Patients with endometriomas of less than 3cm in size or more than 8cm in size
- Pre-surgical evidence of reduced ovarian reserve
- Pregnant patients
- Patients unable to give informed consent e.g. patients with mental incapacity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Royal Derby Hospital
Derby, DE22 3NE, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Saad Amer, MD, MRCOG
University of Nottingham and Derby Hospitals NHS foundation Trust
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor in Gynaecology
Study Record Dates
First Submitted
August 25, 2011
First Posted
August 30, 2011
Study Start
April 1, 2011
Primary Completion
August 1, 2012
Study Completion
February 1, 2013
Last Updated
August 30, 2011
Record last verified: 2011-08